Literature DB >> 25201881

LRRK2 directing ER-to-Golgi transport? (ER)yES!

Bingwei Lu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25201881      PMCID： PMC4253518          DOI： 10.15252/embj.201489832

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  11 in total

Review 1.  LRRK2 and Parkinson disease.

Authors:  Justus C Dächsel; Matthew J Farrer
Journal:  Arch Neurol       Date:  2010-05

2.  LRRK2 function on actin and microtubule dynamics in Parkinson disease.

Authors:  Loukia Parisiadou; Huaibin Cai
Journal:  Commun Integr Biol       Date:  2010-09

3.  Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.

Authors:  Antony A Cooper; Aaron D Gitler; Anil Cashikar; Cole M Haynes; Kathryn J Hill; Bhupinder Bhullar; Kangning Liu; Kexiang Xu; Katherine E Strathearn; Fang Liu; Songsong Cao; Kim A Caldwell; Guy A Caldwell; Gerald Marsischky; Richard D Kolodner; Joshua Labaer; Jean-Christophe Rochet; Nancy M Bonini; Susan Lindquist
Journal:  Science       Date:  2006-06-22       Impact factor: 47.728

4.  Organisation of human ER-exit sites: requirements for the localisation of Sec16 to transitional ER.

Authors:  Helen Hughes; Annika Budnik; Katy Schmidt; Krysten J Palmer; Judith Mantell; Chris Noakes; Andrew Johnson; Deborah A Carter; Paul Verkade; Peter Watson; David J Stephens
Journal:  J Cell Sci       Date:  2009-07-28       Impact factor: 5.285

5.  Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.

Authors:  Stephan Gehrke; Yuzuru Imai; Nicholas Sokol; Bingwei Lu
Journal:  Nature       Date:  2010-07-29       Impact factor: 49.962

6.  Efficient protein trafficking requires trailer hitch, a component of a ribonucleoprotein complex localized to the ER in Drosophila.

Authors:  James E Wilhelm; Michael Buszczak; Suzanne Sayles
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

7.  Parkinson disease: from pathology to molecular disease mechanisms.

Authors:  David T Dexter; Peter Jenner
Journal:  Free Radic Biol Med       Date:  2013-02-04       Impact factor: 7.376

8.  Inefficient SRP interaction with a nascent chain triggers a mRNA quality control pathway.

Authors:  Andrey L Karamyshev; Anna E Patrick; Zemfira N Karamysheva; Dustin S Griesemer; Henry Hudson; Sandra Tjon-Kon-Sang; IngMarie Nilsson; Hendrik Otto; Qinghua Liu; Sabine Rospert; Gunnar von Heijne; Arthur E Johnson; Philip J Thomas
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

9.  Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

Authors:  Xian Lin; Loukia Parisiadou; Xing-Long Gu; Lizhen Wang; Hoon Shim; Lixin Sun; Chengsong Xie; Cai-Xia Long; Wan-Jou Yang; Jinhui Ding; Zsu Zsu Chen; Paul E Gallant; Jung-Hwa Tao-Cheng; Gay Rudow; Juan C Troncoso; Zhihua Liu; Zheng Li; Huaibin Cai
Journal:  Neuron       Date:  2009-12-24       Impact factor: 17.173

10.  Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.

Authors:  Hyun Jin Cho; Jia Yu; Chengsong Xie; Parvathi Rudrabhatla; Xi Chen; Junbing Wu; Loukia Parisiadou; Guoxiang Liu; Lixin Sun; Bo Ma; Jinhui Ding; Zhihua Liu; Huaibin Cai
Journal:  EMBO J       Date:  2014-09-08       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.